Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hepatic arterial infusion (HAI) of 4’epirubicin (EPI) in the treatment of primary hepatocellular carcinoma (HCC)

Hepatic arterial infusion (HAI) of 4’epirubicin (EPI) in the treatment of primary hepatocellular carcinoma (HCC). Proc Annu Meet Am Soc Clin Oncol. 1988; 7:A398.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.